291 related articles for article (PubMed ID: 15712220)
21. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
22. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
Borsellino N; Bonavida B; Ciliberto G; Toniatti C; Travali S; D'Alessandro N
Cancer; 1999 Jan; 85(1):134-44. PubMed ID: 9921985
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
Malinowska K; Neuwirt H; Cavarretta IT; Bektic J; Steiner H; Dietrich H; Moser PL; Fuchs D; Hobisch A; Culig Z
Endocr Relat Cancer; 2009 Mar; 16(1):155-69. PubMed ID: 19011039
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells.
Méndez-Samperio P; Trejo A; Pérez A
Cell Immunol; 2008 Jan; 251(1):37-42. PubMed ID: 18423589
[TBL] [Abstract][Full Text] [Related]
25. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
[TBL] [Abstract][Full Text] [Related]
26. Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakanishi T; Nakae H; Matsuo T
J Nutr Biochem; 2010 Jul; 21(7):659-64. PubMed ID: 19616927
[TBL] [Abstract][Full Text] [Related]
27. p42/p44 Mitogen-activated protein kinase signal transduction pathway regulates interleukin-6 expression in PC3 cells, a line of hormone-refractory prostate cancer cells.
Koul S; Huang M; Chaturvedi L; Meacham RB; Koul HK
Ann N Y Acad Sci; 2004 Dec; 1030():253-7. PubMed ID: 15659804
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
29. Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor.
Tamura S; Morikawa Y; Senba E
Neuroscience; 2005; 133(3):797-806. PubMed ID: 15893881
[TBL] [Abstract][Full Text] [Related]
30. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
31. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
Matthews VB; Knight B; Tirnitz-Parker JE; Boon J; Olynyk JK; Yeoh GC
Exp Cell Res; 2005 May; 306(1):252-63. PubMed ID: 15878349
[TBL] [Abstract][Full Text] [Related]
32. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1beta-induced chemokine secretion via MAP kinase signaling pathways.
Fyfe M; Bergström M; Aspengren S; Peterson A
Cytokine; 2005 Sep; 31(5):358-67. PubMed ID: 16095910
[TBL] [Abstract][Full Text] [Related]
33. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of interleukin-1beta-induced GDNF release from rat glioma cells.
Tanabe K; Nishimura K; Dohi S; Kozawa O
Brain Res; 2009 Jun; 1274():11-20. PubMed ID: 19362079
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 is a direct mediator of T cell migration.
Weissenbach M; Clahsen T; Weber C; Spitzer D; Wirth D; Vestweber D; Heinrich PC; Schaper F
Eur J Immunol; 2004 Oct; 34(10):2895-906. PubMed ID: 15368306
[TBL] [Abstract][Full Text] [Related]
36. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
Kooijman R; Himpe E; Potikanond S; Coppens A
Growth Horm IGF Res; 2007 Oct; 17(5):383-91. PubMed ID: 17513150
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
39. Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-alpha- and dexamethasone-stimulated human periodontal ligament cells.
Lee HJ; Cho JW; Kim SC; Kang KH; Lee SK; Pi SH; Lee SK; Kim EC
Cytokine; 2006 Jul; 35(1-2):67-76. PubMed ID: 16949835
[TBL] [Abstract][Full Text] [Related]
40. Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals.
Ishikawa H; Tsuyama N; Liu S; Abroun S; Li FJ; Otsuyama K; Zheng X; Ma Z; Maki Y; Iqbal MS; Obata M; Kawano MM
Oncogene; 2005 Sep; 24(41):6328-32. PubMed ID: 15940250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
